| Main/Interaction factor |
|
| P value | Control |
|
|
|
|
| % |
| NIS |
|
|
| 93 |
| COC |
|
|
| 88 |
| LSD (0.05) |
|
|
| 5 |
|
|
|
|
|
|
| Formulation 1 | NIS | MAT 0 |
| 86 |
|
|
| MAT 10 |
| 85 |
|
|
| MAT 30 |
| 85 |
|
|
| MAT 60 |
| 100 |
|
|
| MAT 120 |
| 94 |
|
|
| MAT 240 |
| 100 |
|
| COC | MAT 0 |
| 100 |
|
|
| MAT 10 |
| 95 |
|
|
| MAT 30 |
| 79 |
|
|
| MAT 60 |
| 100 |
|
|
| MAT 120 |
| 98 |
|
|
| MAT 240 |
| 93 |
| Formulation 2 | NIS | MAT 0 |
| 90 |
|
|
| MAT 10 |
| 89 |
|
|
| MAT 30 |
| 89 |
|
|
| MAT 60 |
| 83 |
|
|
| MAT 120 |
| 88 |
|
|
| MAT 240 |
| 71 |
|
| COC | MAT 0 |
| 79 |
|
|
| MAT 10 |
| 90 |
|
|
| MAT 30 |
| 87 |
|
|
| MAT 60 |
| 100 |
|
|
| MAT 120 |
| 96 |
|
|
| MAT 240 |
| 100 |
| LSD (0.05) |
|
|
| 3 |
|
|
|
|
|
|
| Formulation |
|
| 0.0556 |
|
| Adjuvant |
|
| 0.0407 |
|
| MAT |
|
| 0.1159 |
|
| Formulation × adjuvant |
|
| 0.3040 |
|
| Formulation × MAT |
|
| 0.2892 |
|
| Adjuvant × MAT |
|
| 0.4768 |
|
| Formulation × adjuvant × MAT |
|
| 0.0063 |
|